Elisabeth Sandoval Little
CIK 1632295 · CCO & EVP, Corporate Strategy · last filed 2026-06-10
Elisabeth Sandoval Little is a CCO & EVP, Corporate Strategy who has filed 32 SEC Form 4 insider transactions across 7 companies since 2015. The most recent filing, for PRCT, was dated Jun 10, 2026. Across all open-market trades the lifetime net is −$6.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $408.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$408.1K
7
32
-$6.51M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PRCT | Director | 15,876 | $25.70 | $408.1K | $0 | 6 | 2026-06-10 |
| VYNE | Director | — | $0.65 | — | $0 | 6 | 2025-12-15 |
| Satsuma Pharmaceuticals, Inc. (STSA) Delisted | Director | — | $1.10 | — | $0 | 4 | 2023-06-08 |
| Intersect ENT, Inc. (XENT) Delisted | Director | — | $28.24 | — | $0 | 2 | 2022-05-16 |
| VYNE Therapeutics Inc. (MNLO) Delisted | Director | — | — | — | $0 | 4 | 2020-08-05 |
| ALDER BIOPHARMACEUTICALS INC (ALDR) Delisted | CCO & EVP, Corporate Strategy | — | — | — | $0 | 4 | 2018-02-21 |
| KYTHERA BIOPHARMACEUTICALS INC (KYTH) Delisted | Chief Commerical Officer | 0 | — | — | -$6.51M | 6 | 2015-10-02 |
Recent Filings
32 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-10 | PRCT | Grant (A) | +3,315 | $0 | EDGAR |
| 2025-12-15 | VYNE | Grant (A) | — | $0 | EDGAR |
| 2025-06-12 | PRCT | Grant (A) | +1,538 | $0 | EDGAR |
| 2024-12-13 | VYNE | Grant (A) | — | $0 | EDGAR |
| 2024-06-06 | PRCT | Grant (A) | +1,376 | $0 | EDGAR |
| 2024-01-03 | VYNE | Grant (A) | — | $0 | EDGAR |
| 2023-12-15 | VYNE | Grant (A) | — | $0 | EDGAR |
| 2023-06-16 | PRCT | Grant (A) | +2,711 | $0 | EDGAR |
| 2023-06-08 | Satsuma Pharmaceuticals, Inc. (STSA) Delisted | Disp (D) | — | $0 | EDGAR |
| 2022-08-12 | VYNE | Grant (A) | — | $0 | EDGAR |